Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-κB-IL6-STAT3 axis

被引：0
|
作者：
Weibo Zhong
Kaihui Wu
Zining Long
Xumin Zhou
Chuanfan Zhong
Shuo Wang
Houhua Lai
Yufei Guo
Daojun Lv
Jianming Lu
Xiangming Mao
机构：
[1] Southern Medical University,Department of Urology, Zhujiang Hospital
[2] The Third Affiliated Hospital of Guangzhou Medical University,Department of Urology
[3] Guangzhou Medical University,Department of Andrology, Guangzhou First People’s Hospital, School of Medicine
来源：
Microbiome | / 10卷
关键词：
Gut dysbiosis; Prostate cancer; Lipopolysaccharide; NF-κB-IL6-STAT3 axis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] circPTPN12 promotes the progression and sunitinib resistance of renal cancer via hnRNPM/IL-6/STAT3 pathway
    Shou, Yi
    Yue, Changjie
    Wang, Qi
    Liu, Jingchong
    Xu, Jiaju
    Miao, Qi
    Liu, Di
    Yang, Hongmei
    Liu, Yuenan
    Zhang, Xiaoping
    CELL DEATH & DISEASE, 2023, 14 (03):
  • [22] circPTPN12 promotes the progression and sunitinib resistance of renal cancer via hnRNPM/IL-6/STAT3 pathway
    Yi Shou
    Changjie Yue
    Qi Wang
    Jingchong Liu
    Jiaju Xu
    Qi Miao
    Di Liu
    Hongmei Yang
    Yuenan Liu
    Xiaoping Zhang
    Cell Death & Disease, 14
  • [23] Neuronatin Promotes the Progression of Non-Small Cell Lung Cancer by Activating the NF-κB Signaling
    Xiong, Huanwen
    Chen, Guohua
    Fang, Ke
    Gu, Weiguo
    Qiu, Feng
    CURRENT CANCER DRUG TARGETS, 2024, 24 (11) : 1128 - 1143
  • [24] IL-1β promotes cervical cancer through activating NF-κB/CCL-2
    Tao, Limin
    Liu, Sisun
    Xiong, Juying
    Yang, Huimin
    Wu, Yanfang
    Xu, Anli
    Gong, Yanfeng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2021, 14 (04): : 426 - 433
  • [25] STAT3 Induction of miR-146b Forms a Feedback Loop to Inhibit the NF-κB to IL-6 Signaling Axis and STAT3-Driven Cancer Phenotypes
    Xiang, Michael
    Birkbak, Nicolai J.
    Vafaizadeh, Vida
    Walker, Sarah R.
    Yeh, Jennifer E.
    Liu, Suhu
    Kroll, Yasmin
    Boldin, Mark
    Taganov, Konstantin
    Groner, Bernd
    Richardson, Andrea L.
    Frank, David A.
    SCIENCE SIGNALING, 2014, 7 (310)
  • [26] Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-κB
    Kim, Sun Mi
    Lee, So Yong
    Cho, Jin Suk
    Son, Seung Mo
    Choi, Sang Sook
    Yun, Yeo Pyo
    Yoo, Hwan Soo
    Yoon, Do Young
    Oh, Ki-Wan
    Han, Sang Bae
    Hong, Jin Tae
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 631 (1-3) : 1 - 9
  • [27] Endolysosomal ion channel MCOLN2 (Mucolipin-2) promotes prostate cancer progression via IL-1β/NF-κB pathway
    Yu, Hongyan
    Xie, Mingxu
    Meng, Zhaoyue
    Lo, Chun-Yin
    Chan, Franky Leung
    Jiang, Liwen
    Meng, Xiangqi
    Yao, Xiaoqiang
    BRITISH JOURNAL OF CANCER, 2021, 125 (10) : 1420 - 1431
  • [28] Endolysosomal ion channel MCOLN2 (Mucolipin-2) promotes prostate cancer progression via IL-1β/NF-κB pathway
    Hongyan Yu
    Mingxu Xie
    Zhaoyue Meng
    Chun-Yin Lo
    Franky Leung Chan
    Liwen Jiang
    Xiangqi Meng
    Xiaoqiang Yao
    British Journal of Cancer, 2021, 125 : 1420 - 1431
  • [29] Nuclear Factor-κB(NF-κB)/Interleukin-6 (IL-6) pathway activation confers resistance to docetaxel (D) in hormone-independent prostate cancer (HIPC).
    Domingo-Domenech, J
    Rovira, A
    Codony-Servat, J
    Filella, X
    Montagut, C
    Ross, JS
    Rolfe, M
    Gascon, P
    Albanell, J
    Mellado, B
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 868S - 868S
  • [30] DOK3 promotes proliferation and inhibits apoptosis of prostate cancer via the NF-κB signaling pathway
    Jin Kun
    Qiu Shi
    Chen Bo
    Zhang Zilong
    Zhang Chichen
    Zhou Xianghong
    Yang Lu
    Ai Jianzhong
    Wei Qiang
    中华医学杂志英文版, 2023, 136 (04)
12345